Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Other tyrosine protein kinases" refers to a broad and heterogeneous classification of enzymes that facilitate the transfer of a phosphate group from ATP to specific tyrosine residues on substrate proteins (UniProt, 2023). This grouping is typically used in pharmacological and genomic databases to categorize tyrosine kinases that do not fall into the primary established families such as Src, Abl, or the various receptor tyrosine kinase subfamilies (Manning et al., 2002). These enzymes are essential components of cellular signal transduction pathways, regulating critical processes including cell growth, differentiation, and survival (NCBI, 2024). Dysregulation, often through mutation or overexpression, of these kinases is a primary driver in many types of cancer and inflammatory diseases (PubMed, 2023). While many small-molecule inhibitors like imatinib and dasatinib target specific tyrosine kinases, they often exhibit activity across multiple members of this broad class due to the conserved nature of the ATP-binding pocket (PubChem, 2024). Consequently, this category represents a collection of potential therapeutic targets rather than a single, discrete molecular entity.
Inhibition of the catalytic activity of the kinase domain, typically by competing with ATP for the binding site, thereby preventing the phosphorylation of substrate proteins and interrupting downstream signaling pathways (PubChem, 2024).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other tyrosine protein kinases.